---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-116219"
form_type: "8-K"
ticker: "INKT"
cik: "0001840229"
company_name: "MiNK Therapeutics, Inc."
filed_at: "2026-03-19T23:59:59+00:00"
generated_at: "2026-05-15T09:40:56.452555+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# MiNK Therapeutics appoints new Principal Financial Officer and Principal Accounting Officer

## Summary
- Melissa Orilall, VP Global Financial Operations at Agenus, appointed Principal Financial Officer effective March 13, 2026.
- Austin Charette, Senior Director Financial Reporting & Compliance at Agenus, appointed Principal Accounting Officer effective same date.
- Both provide services via Amended Intercompany Services Agreement with Agenus; no direct compensation from MiNK.
- No new arrangements or modifications tied to these designations.

## SEC filing metadata
- accession: 0001193125-26-116219
- form_type: 8-K
- ticker: INKT
- cik: 0001840229
- company_name: MiNK Therapeutics, Inc.
- filed_at: 2026-03-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/0001193125-26-116219-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840229/000119312526116219/inkt-20260313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-116219
- JSON: https://secwatch.observer/filing/0001193125-26-116219.json
- Plain text: https://secwatch.observer/filing/0001193125-26-116219.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.